These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3434410)

  • 21. Enhancement drugs and the athlete.
    Botrè F; Pavan A
    Neurol Clin; 2008 Feb; 26(1):149-67; ix. PubMed ID: 18295088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anabolic steroids and ergogenic aids.
    Hough DO
    Am Fam Physician; 1990 Apr; 41(4):1157-64. PubMed ID: 2181832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The psychology behind doping in sport.
    Ehrnborg C; Rosén T
    Growth Horm IGF Res; 2009 Aug; 19(4):285-7. PubMed ID: 19477668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Social capital: implications from an investigation of illegal anabolic steroid networks.
    Maycock BR; Howat P
    Health Educ Res; 2007 Dec; 22(6):854-63. PubMed ID: 17584951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doping, drugs and drug abuse among adolescents in the State of Thuringia (Germany): prevalence, knowledge and attitudes.
    Wanjek B; Rosendahl J; Strauss B; Gabriel HH
    Int J Sports Med; 2007 Apr; 28(4):346-53. PubMed ID: 17024651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-admitted behavior and perceived use of performance-enhancing vs psychoactive drugs among competitive athletes.
    Uvacsek M; Nepusz T; Naughton DP; Mazanov J; Ránky MZ; Petróczi A
    Scand J Med Sci Sports; 2011 Apr; 21(2):224-34. PubMed ID: 19903314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stay alert for performance-enhancing substance use.
    Jarvi JF
    JAAPA; 2004 Dec; 17(12):36-9. PubMed ID: 15631019
    [No Abstract]   [Full Text] [Related]  

  • 28. Psychological characteristics of adolescent steroid users.
    Burnett KF; Kleiman ME
    Adolescence; 1994; 29(113):81-9. PubMed ID: 8036984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anabolic steroid abuse and mental disorder].
    Nakatani Y; Udagawa M
    Arukoru Kenkyuto Yakubutsu Ison; 1995 Oct; 30(5):333-47. PubMed ID: 8534221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
    Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I
    Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug use in English professional football.
    Waddington I; Malcolm D; Roderick M; Naik R
    Br J Sports Med; 2005 Apr; 39(4):e18; discussion e18. PubMed ID: 15793076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of drugs in swimming.
    Puffer JC
    Clin Sports Med; 1986 Jan; 5(1):77-89. PubMed ID: 3512106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is abstinence an alternative? Predicting adolescent athletes' intentions to use performance enhancing substances.
    Dodge T; Jaccard JJ
    J Health Psychol; 2008 Jul; 13(5):703-11. PubMed ID: 18519443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance-enhancing drug use.
    Green GA
    Orthopedics; 2009 Sep; 32(9):. PubMed ID: 19751025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance-enhancing drugs.
    Ghaphery NA
    Orthop Clin North Am; 1995 Jul; 26(3):433-42. PubMed ID: 7609958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance-enhancing drugs and supplements in women and girls.
    Matich AJ
    Curr Sports Med Rep; 2007 Dec; 6(6):387-91. PubMed ID: 18001612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Popular ergogenic drugs and supplements in young athletes.
    Calfee R; Fadale P
    Pediatrics; 2006 Mar; 117(3):e577-89. PubMed ID: 16510635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart lesions associated with anabolic steroid abuse: comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbits.
    Fanton L; Belhani D; Vaillant F; Tabib A; Gomez L; Descotes J; Dehina L; Bui-Xuan B; Malicier D; Timour Q
    Exp Toxicol Pathol; 2009 Jul; 61(4):317-23. PubMed ID: 19027274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
    Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L;
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Substance abuse in recreational exercise].
    Bernardin J; Kohler B
    Dtsch Med Wochenschr; 2010 Mar; 135(11):522-6. PubMed ID: 20221969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.